Shockwave Lithotripsy Effective in Selected Cases of Distal Ureteric Stones
Patients with stones smaller than 7 mm are more likely have a successful treatment than those with larger stones, investigators concluded.
EAU Congress
Prostate Cancer Outcomes After HIFU Characterized
Patients who underwent HIFU total ablation of the prostate had a 30-month failure-free survival rate similar to that of patients treated with radical prostatectomy, according to investigators.
UTUC Adjuvant Chemotherapy Beneficial in Selected Cases
Adjuvant chemotherapy prolongs survival among patients with negative surgical margins regardless of number of positive lymph nodes.
Tamsulosin After Shockwave Lithotripsy Ups Stone-Free Rate
A recent study may support use of tamsulosin as medical expulsion therapy following shockwave lithotripsy.
Data Support Trimodal Therapy for Muscle-Invasive Bladder Cancer
A propensity-score matched comparison revealed no significant difference in oncologic outcomes between radical cystectomy and trimodal therapy.
New Insight Into Surgical Treatment of Metastatic Renal Cell Carcinoma
Cytoreductive partial nephrectomy and robotic radiosurgery appear to have a place in the treatment of metastatic renal cell carcinoma, research findings suggest.
Pathologic Outcomes in Prostate Cancer Cases Worsened During Pandemic
Compared with before the pandemic, men undergoing radical prostatectomy during the pandemic were more likely to have extraprostatic disease, according to investigators.
Apalutamide Prolongs Survival in mCSPC Regardless of Disease Volume
A final analysis of the TITAN trial shows that apalutamide vs placebo added to ADT significantly lowers the risk of death and castration-resistant disease in men with metastatic castration-sensitive prostate cancer.
PSMA-PET/CT May Detect Prostate Cancer More Accurately Than mpMRI
Early results support a fully-powered trial of 18F-PSMA PET/CT for prostate cancer detection, according to the investigators.
Study: Risk Score Should Guide Deferral of Cytoreductive Nephrectomy
Ideal patient selection for a deferred cytoreductive nephrectomy should include an assessment of Memorial Sloan Kettering Cancer Center risk score, according to investigators.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in EAU Congress
Loading... 
Loading...